 | • レポートコード：20QY06-04327 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、リラグルチド薬のグローバル市場について種類別（ヴィクトーザ、サクセンダ）、用途別（2型糖尿病、肥満）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・リラグルチド薬市場の概要 ・世界の主要地域別リラグルチド薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のリラグルチド薬市場規模2015-2026：種類別（ヴィクトーザ、サクセンダ） ・世界のリラグルチド薬市場規模2015-2026：用途別（2型糖尿病、肥満） ・リラグルチド薬の北米市場規模2015-2020 ・リラグルチド薬のヨーロッパ市場規模2015-2020 ・リラグルチド薬の中国市場規模2015-2020 ・リラグルチド薬の日本市場規模2015-2020 ・リラグルチド薬の東南アジア市場規模2015-2020 ・リラグルチド薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novo Nordisk、Mylan） ・リラグルチド薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・リラグルチド薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Liraglutide Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Liraglutide Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Liraglutide Drugs industry.
Based on our recent survey, we have several different scenarios about the Liraglutide Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Liraglutide Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Liraglutide Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Liraglutide Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Liraglutide Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Liraglutide Drugs market. The report also includes nautical information, where it shows Liraglutide Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Liraglutide Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Liraglutide Drugs market.
Geographical Analysis:
Based on region, the global Liraglutide Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Liraglutide Drugs market are
Novo Nordisk
Mylan
…
Segment by Type
Victoza
Saxenda
Segment by Application
Type 2 Diabetes
Obesity
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Liraglutide Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Liraglutide Drugs market.
• The market share of the global Liraglutide Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Liraglutide Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Liraglutide Drugs market.
1 Liraglutide Drugs Market Overview
1.1 Liraglutide Drugs Product Scope
1.2 Liraglutide Drugs Segment by Type
1.2.1 Global Liraglutide Drugs Sales by Type (2020-2026)
1.2.2 Victoza
1.2.3 Saxenda
1.3 Liraglutide Drugs Segment by Application
1.3.1 Global Liraglutide Drugs Sales Comparison by Application (2020-2026)
1.3.2 Type 2 Diabetes
1.3.3 Obesity
1.4 Liraglutide Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Liraglutide Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Liraglutide Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Liraglutide Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Liraglutide Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Liraglutide Drugs Industry
1.5.1.1 Liraglutide Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Liraglutide Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Liraglutide Drugs Players to Combat Covid-19 Impact
2 Liraglutide Drugs Estimate and Forecast by Region
2.1 Global Liraglutide Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Liraglutide Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Liraglutide Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Liraglutide Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Liraglutide Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Liraglutide Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Liraglutide Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Liraglutide Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Liraglutide Drugs Estimates and Projections (2015-2026)
2.4.3 China Liraglutide Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Liraglutide Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Liraglutide Drugs Estimates and Projections (2015-2026)
2.4.6 India Liraglutide Drugs Estimates and Projections (2015-2026)
3 Global Liraglutide Drugs Competition Landscape by Players
3.1 Global Top Liraglutide Drugs Players by Sales (2015-2020)
3.2 Global Top Liraglutide Drugs Players by Revenue (2015-2020)
3.3 Global Liraglutide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide Drugs as of 2019)
3.4 Global Liraglutide Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Liraglutide Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Liraglutide Drugs Players (Opinion Leaders)
4 Global Liraglutide Drugs Market Size by Type
4.1 Global Liraglutide Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Liraglutide Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Liraglutide Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Liraglutide Drugs Price by Type (2014-2020)
4.2 Global Liraglutide Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Liraglutide Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Liraglutide Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Liraglutide Drugs Price Forecast by Type (2021-2026)
5 Global Liraglutide Drugs Market Size by Application
5.1 Global Liraglutide Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Liraglutide Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Liraglutide Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Liraglutide Drugs Price by Application (2015-2020)
5.2 Global Liraglutide Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Liraglutide Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Liraglutide Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Liraglutide Drugs Price Forecast by Application (2021-2026)
3 North America Liraglutide Drugs Market Facts & Figures
3.2 North America Liraglutide Drugs Sales Market Share by Company (2015-2020)
3.3 North America Liraglutide Drugs Sales Market Share by Type (2015-2020)
3.4 North America Liraglutide Drugs Sales Market Share by Application (2015-2020)
4 Europe Liraglutide Drugs Market Facts & Figures
4.2 Europe Liraglutide Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Liraglutide Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Liraglutide Drugs Sales Market Share by Application (2015-2020)
5 China Liraglutide Drugs Market Facts & Figures
5.2 China Liraglutide Drugs Sales Market Share by Company (2015-2020)
5.3 China Liraglutide Drugs Sales Market Share by Type (2015-2020)
5.4 China Liraglutide Drugs Sales Market Share by Application (2015-2020)
6 Japan Liraglutide Drugs Market Facts & Figures
6.2 Japan Liraglutide Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Liraglutide Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Liraglutide Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Liraglutide Drugs Market Facts & Figures
7.2 Southeast Asia Liraglutide Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Liraglutide Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Liraglutide Drugs Sales Market Share by Application (2015-2020)
8 India Liraglutide Drugs Market Facts & Figures
8.2 India Liraglutide Drugs Sales Market Share by Company (2015-2020)
8.3 India Liraglutide Drugs Sales Market Share by Type (2015-2020)
8.4 India Liraglutide Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Liraglutide Drugs Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Liraglutide Drugs Corporation Information
12.1.2 Novo Nordisk Liraglutide Drugs Business Overview and Total Revenue
12.1.3 Novo Nordisk Liraglutide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novo Nordisk Liraglutide Drugs Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Mylan
12.2.1 Mylan Liraglutide Drugs Corporation Information
12.2.2 Mylan Liraglutide Drugs Business Overview and Total Revenue
12.2.3 Mylan Liraglutide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mylan Liraglutide Drugs Products Offered
12.2.5 Mylan Recent Development
…
13 Liraglutide Drugs Manufacturing Cost Analysis
13.1 Liraglutide Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Liraglutide Drugs
13.4 Liraglutide Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Liraglutide Drugs Distributors List
14.3 Liraglutide Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Liraglutide Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Liraglutide Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Liraglutide Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Liraglutide Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Liraglutide Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Liraglutide Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Liraglutide Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Liraglutide Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Liraglutide Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Liraglutide Drugs Revenue Share by Region (2015-2020)
Table 13. Global Liraglutide Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Liraglutide Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Liraglutide Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Liraglutide Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Liraglutide Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Liraglutide Drugs Sales Share by Company (2015-2020)
Table 19. Global Liraglutide Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Liraglutide Drugs Revenue Share by Company (2015-2020)
Table 21. Global Liraglutide Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide Drugs as of 2019)
Table 22. Global Liraglutide Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Liraglutide Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Liraglutide Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Liraglutide Drugs Players
Table 27. Global Liraglutide Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Liraglutide Drugs Sales Share by Type (2015-2020)
Table 29. Global Liraglutide Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Liraglutide Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Liraglutide Drugs Sales Share by Type (2021-2026)
Table 32. Global Liraglutide Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Liraglutide Drugs Revenue Share by Type (2021-2026)
Table 34. Global Liraglutide Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Liraglutide Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Liraglutide Drugs Sales Share by Application (2015-2020)
Table 37. Global Liraglutide Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Liraglutide Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Liraglutide Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Liraglutide Drugs Sales Share by Application (2021-2026)
Table 41. Global Liraglutide Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Liraglutide Drugs Revenue Share by Application (2021-2026)
Table 43. Global Liraglutide Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Liraglutide Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Liraglutide Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Liraglutide Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Liraglutide Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Liraglutide Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Liraglutide Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Liraglutide Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Liraglutide Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 56. China Liraglutide Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Liraglutide Drugs Sales Market Share by Company (2015-2020)
Table 58. China Liraglutide Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 60. China Liraglutide Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Liraglutide Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Liraglutide Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Liraglutide Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Liraglutide Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Liraglutide Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Liraglutide Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Liraglutide Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Liraglutide Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 74. India Liraglutide Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Liraglutide Drugs Sales Market Share by Company (2015-2020)
Table 76. India Liraglutide Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 78. India Liraglutide Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 80. Novo Nordisk Corporation Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk Liraglutide Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novo Nordisk Liraglutide Drugs Product
Table 84. Novo Nordisk Recent Development
Table . Mylan Corporation Information
Table . Mylan Description and Business Overview
Table . Mylan Liraglutide Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Mylan Liraglutide Drugs Product
Table . Mylan Recent Development
Table 90. Production Base and Market Concentration Rate of Raw Material
Table 91. Key Suppliers of Raw Materials
Table 92. Liraglutide Drugs Distributors List
Table 93. Liraglutide Drugs Customers List
Table 94. Market Key Trends
Table 95. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 96. Key Challenges
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Liraglutide Drugs Product Picture
Figure 2. Global Liraglutide Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liraglutide Drugs Market Share by Application in 2020 & 2026
Figure 6. Type 2 Diabetes Examples
Figure 7. Obesity Examples
Figure 8. Global Liraglutide Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Liraglutide Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Liraglutide Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Liraglutide Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Liraglutide Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Liraglutide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Liraglutide Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Liraglutide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Liraglutide Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Liraglutide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Liraglutide Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Liraglutide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Liraglutide Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Liraglutide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Liraglutide Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Liraglutide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Liraglutide Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Liraglutide Drugs Players Market Share by Revenue in Liraglutide Drugs 2015 & 2019
Figure 26. Liraglutide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Liraglutide Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Liraglutide Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Liraglutide Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Liraglutide Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Liraglutide Drugs Sales Market Share by Type in 2019
Figure 32. United States Liraglutide Drugs Sales Market Share by Type in 2019
Figure 33. Europe Liraglutide Drugs Sales Market Share by Company in 2019
Figure 34. Europe Liraglutide Drugs Sales Market Share by Type in 2019
Figure 35. Europe Liraglutide Drugs Sales Market Share by Application in 2019
Figure 36. China Liraglutide Drugs Sales Market Share by Company in 2019
Figure 37. China Liraglutide Drugs Sales Market Share by Type in 2019
Figure 38. China Liraglutide Drugs Sales Market Share by Application in 2019
Figure 39. Japan Liraglutide Drugs Sales Market Share by Company in 2019
Figure 40. Japan Liraglutide Drugs Sales Market Share by Type in 2019
Figure 41. Japan Liraglutide Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Liraglutide Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Liraglutide Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Liraglutide Drugs Sales Market Share by Application in 2019
Figure 45. India Liraglutide Drugs Sales Market Share by Company in 2019
Figure 46. India Liraglutide Drugs Sales Market Share by Type in 2019
Figure 47. India Liraglutide Drugs Sales Market Share by Application in 2019
Figure 48. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Liraglutide Drugs
Figure 52. Manufacturing Process Analysis of Liraglutide Drugs
Figure 53. Liraglutide Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
リラグルチドの世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…- エクセナチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Exenatide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drugs Market The global Endocrine System Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Endocrine System Drugs Scope and Market Size The global…
- コリン作動薬の世界市場レポート2020 Market Analysis and Insights: Global Cholinergic Drugs Market The global Cholinergic Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cholinergic Drugs Scope and Market Size The global Cholinergic Dr…
- 糖尿病薬の世界市場レポート2020 A recently published report by QY Research titled Global Diabetes Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate dat…